Are you Dr. Beeker?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 127 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1700 Spring Hill Ave
Ste 100
Mobile, AL 36604Phone+1 251-435-1200Fax+1 251-435-6357
Summary
- Dr. Thaddeus Beeker, MD is an oncologist in Mobile, Alabama. He is currently licensed to practice medicine in Alabama, Florida, and Tennessee. He is affiliated with Mobile Infirmary Medical Center, Springhill Medical Center, and USA Health Providence Hospital.
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1994 - 1995- Vanderbilt University Medical CenterResidency, Internal Medicine, 1992 - 1993
- Vanderbilt University Medical CenterResidency, Internal Medicine, 1989 - 1991
Brody School of Medicine at East Carolina UniversityClass of 1989
Certifications & Licensure
AL State Medical License 1995 - 2024
FL State Medical License 2006 - 2011
TN State Medical License 1990 - 1996- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Start of enrollment: 2008 Mar 01
- S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer Start of enrollment: 2011 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsRecurrent Hodgkin's disease after bone marrow transplantation.Imran Shahab, John P. Greer, Thaddeus A. Beeker, Steven N. Wolff, Robert D. Collins
American Journal of Clinical Pathology. 1997-01-01
Press Mentions
- Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast CancerJanuary 22nd, 2021
Professional Memberships
- Member
